Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs - Trial 2011-001105-28
Access comprehensive clinical trial information for 2011-001105-28 through Pure Global AI's free database. This phase not specified trial is sponsored by Eisai Inc. and is currently status unknown. The study focuses on Epilepsy.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2011-001105-28
Trial Details
EU Clinical Trials Register • 2011-001105-28
Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs
Study Focus
Sponsor & Location
Eisai Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Only during Core Study:
ICD-10 Classifications
Epilepsy
Epilepsy, unspecified
Other epilepsy
Status epilepticus
Other status epilepticus
Data Source
EU Clinical Trials Register
2011-001105-28
Non-Device Trial